Markets
ARK sells 10X Genomics, buys Perceptive Capital in latest trades
Cathie Wood's ARK Investment Management trimmed exposure to 10X Genomics while initiating a stake in Perceptive Capital, reflecting a shift in its portfolio strategy.
UK allocates £65 million to support farmers amid drought
Government announces emergency funding to mitigate water shortages and crop losses as dry conditions persist across England.
Anthropic IPO valuation tied to $190-200 bln 2028 revenue forecast
AI startup Anthropic's market debut hinges on projections of $190-200 billion in revenue by 2028, sources familiar with the matter say.
Oil markets grapple with demand uncertainty amid mixed signals
Traders weigh conflicting economic data and geopolitical risks as Brent crude hovers near $85 per barrel.
Drones strike residential buildings in Russia's Novorossiysk
Mayor confirms attacks on civilian structures in Black Sea port, amid ongoing regional conflict. No immediate claim of responsibility reported.
Suncorp forecasts FY26 earnings growth, A$606m capital return
Australian insurer Suncorp outlines FY26 earnings growth and plans a A$606 million capital return to shareholders. Outlook reflects improved underwriting and investment income.
Oil prices climb near two-week high on Hormuz closure, Houthi attacks
Brent crude approaches $85 per barrel as shipping disruptions in the Strait of Hormuz and Red Sea strikes by Houthi militants tighten supply risks.
Rakuten shares drop 9% on mobile unit losses, heavy investment
Japanese tech conglomerate’s stock decline follows widening losses in its mobile division and increased capital expenditure, raising concerns over near-term profitability.
Pangaea Q2 2025 slides show TCE rates jump despite earnings miss
Tanker company Pangaea’s Q2 2025 slides indicate a sharp rise in time charter equivalent rates, offsetting weaker-than-expected earnings for the period.
Silexion Therapeutics raises $2.5M in $0.65 share public offering
Biotech firm Silexion Therapeutics priced a public offering of 3.85 million shares at $0.65 each, raising $2.5 million to fund pipeline development.
Dexus Industria FY26 outlook lifts FFO above forecast
FFO for Dexus Industria exceeds guidance while portfolio yields reach 7% in full-year 2026 outlook.
Dexus Industria FY26 slides show FFO beat on pure-play shift
FY2026 outlook slides indicate funds from operations exceeded forecasts as Dexus Industria accelerates its transition to a pure-play logistics property group.
Oil rises on supply concerns amid US-Iran deal uncertainty
Brent crude and WTI futures climb as renewed skepticism over a potential US-Iran nuclear deal stokes fears of reduced Iranian oil exports.
Apax-backed fund prices $8 million OPENLANE share offering
The offering follows a private placement of 8 million shares at $1 each, valuing the company at $8 million. Apax Partners holds a majority stake.
Dollar steady ahead of key U.S. inflation report
Greenback holds near two-week lows as traders await CPI data that could shape Federal Reserve policy expectations.
Laekna’s breast cancer drug application accepted in China
Chinese regulator accepts Laekna’s application for a novel breast cancer therapy, marking a key step toward commercialization in the country’s growing oncology market.
Australia's housing pledge faces builder capacity constraints
Government targets 1.2 million new homes by 2029 amid labor and material shortages, but industry warns of unsustainable build rates.
ARK sells Deere, buys Rocket Lab in latest portfolio shift
Cathie Wood's ARK Investment Management trimmed exposure to Deere & Co. while adding shares of space company Rocket Lab in its latest 13F filing.
Ravencoin RVN drops to record low after network exploit
Mining pools controlling over 50% of Ravencoin's hash rate fork the chain, risking a three-day reorganization and raising transaction security concerns.
U.S. Rep. Gottheimer reports Alphabet trades amid congressional scrutiny
New Jersey Democrat Josh Gottheimer disclosed multiple stock transactions in Alphabet, Meta and other companies, per federal filings. The trades come as lawmakers face heightened scrutiny over potential conflicts of interest.
U.S. Rep. Kevin Hern reports major stock, Treasury trades
Oklahoma Republican discloses significant transactions in equities and government securities, as required by federal ethics rules.
U.S. Congressman discloses trades in Applied Materials, BlackRock, Palo Alto Networks
Rep. John McGuire III reported purchases of shares in three major firms, including a BlackRock ETF, following recent market activity.
U.S. Antimony misses earnings by $0.03, revenue below estimates
Antimony producer reported a per-share loss of $0.04 versus a $0.01 profit forecast, with revenue declining 12% year-over-year.
Gladstone Land Q2 earnings miss estimates by $0.05 per share
Revenue exceeded expectations as the farmland REIT reported Q2 results, though adjusted FFO fell short of analyst forecasts.
U.S. regulators sue Goliath Ventures over $400M crypto fraud
SEC and CFTC allege Goliath Ventures operated a Ponzi scheme, misusing investor funds for luxury spending and earlier payouts instead of promised crypto returns.